Market Size (2024)
$6.75B
Vertical: HealthcareBase Year: 202423 Sections
Market Size (2024)
$6.75B
Projected (2035)
$16.50B
CAGR (2019–2035)
8.8%
Key Players
10+
This report covers Mitral Valve (Stenosis & Regurgitation) Treatment Market with forecasts from 2019 to 2035. 10 key companies are profiled.
The Mitral Valve (Stenosis & Regurgitation) Treatment Market market is projected to grow at a CAGR of 8.8% from 2019 to 2035.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMitral Valve (Stenosis & Regurgitation) Treatment Market
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
Analysis of Mitral Valve (Stenosis & Regurgitation) Treatment Market from 2019 to 2035. Covers North America, Europe, Asia-Pacific, South America, Middle East and Africa.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2024
Historical Period
2019 – 2023
Forecast Period
2025 – 2035
Primary Interviews
150+
Historical data (2019–2024) and forecast period (2024–2035)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket estimates by geography (2035)
InsightMarket Size leads with $7.78B by 2035.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2019 | 2024 | 2035 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $0.44M | $36.41M | $2.28B | 2.7% | 17% |
| Europe | $0.29M | $28.76M | $1.76B | 2.7% | 13% |
| Asia-Pacific | $0.18M | $19.07M | $1.52B | 2.8% | 11% |
| South America | $0.05M | $3.83M | $219.08M | 2.6% | 2% |
| Middle East and Africa | $0.04M | $3.25M | $177.27M | 2.7% | 1% |
| Market Size | $5.00B | $5.93B | $7.78B | 7.7% | 57% |
| Total | $5.00B | $6.02B | $13.74B | 8.8% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Mitral Valve (Stenosis & Regurgitation) Treatment Market covering market dynamics, competitive landscape, and strategic outlook.
The Mitral Valve (Stenosis & Regurgitation) Treatment Market market is projected to reach $16.50B by 2035, growing at 8.8% CAGR.
The Mitral Valve (Stenosis & Regurgitation) Treatment Market market encompasses 6 key regions and multiple market segments, with the study period spanning 2019 to 2035. The market demonstrates a 8.8% compound annual growth rate, reflecting strong underlying demand fundamentals.
The market is segmented across multiple dimensions, with detailed breakdowns available by component, region, and application type to support strategic planning and investment decisions.
This report profiles 10 key companies operating in the Mitral Valve (Stenosis & Regurgitation) Treatment Market market, covering market positioning, product portfolios, and recent developments.
Leading players include Medtronic, Novartis AG, TEVA Pharmaceutical Industries Ltd, Valcare Medical, Affluent Medical, and 5 others.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Mitral Valve (Stenosis & Regurgitation) Treatment Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
Novartis AG
Company Headquarters: Basel, Switzerland Founded: 1996 Workforce: ~126,000 Company Working: Novartis AG (Novartis) was established in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its preceding companies have been known to develop innovative products which can be traced back to over 250 years. The company focuses on the development and marketing of products that contribute to human progress through advances in science and health. It provides products that find applications in cancer, cardio-metabolic, immunology and dermatology, ophthalmology, neuroscience, and respiratory disease areas. Its Sandoz segment offers active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, dermatology, central nervous system (CNS), gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas, among others. It also provides active pharmaceutical ingredients (API) and intermediates primarily antibiotics, protein- or other biotechnology-based products including biosimilars, and biotechnology manufacturing services.
Bayer AG
Edwards Lifesciences Corporation
Artivion
Corcym Group
Valcare Medical
11 interactive charts drawn from the Mitral Valve (Stenosis & Regurgitation) Treatment Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Mitral Valve (Stenosis & Regurgitation) Treatment Market By Country
Global Mitral Valve (Stenosis & Regurgitation) Treatment Market By Mitral Regurgitation-Surgery Type
Global Mitral Valve (Stenosis & Regurgitation) Treatment Market By Mitral Regurgitation-Treatment
Global Mitral Valve (Stenosis & Regurgitation) Treatment Market By Mitral Regurgitation-Etiology
Global Mitral Valve (Stenosis & Regurgitation) Treatment Market By Mitral Stenosis-Surgery Type
Global Mitral Valve (Stenosis & Regurgitation) Treatment Market By Mitral Stenosis-Treatment
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence